Drug Research
Long-Awaited Daxxify By Revance Will Compete With Botox
Revance Therapeutics may soon run into an identity problem with a product that is so eagerly awaited that some people mistakenly call it by...
Clinical Trials
Trodelvy Breast Cancer Drug Makes A Spectacular Comeback
After unimpressive evidence on tumour progression, many Gilead Sciences investors have stopped believing in Trodelvy in HR-positive, HER2-negative breast cancer. But now that the...
News
3 Unusual Foods and Drinks You Should Try at Least Once
If you are a total foodie and you’re looking for some inspiration, you’ve come to the right place. Food trends made for the Gram...
News
5 Ways AI Can Improve The Pharma Industry
Pharmaceuticals are a vital part of the healthcare industry. They help improve the quality of drugs and services they provide, as well as discover...
Drug Research
Introduction of Anti-Evolocumab Antibodies From Bio-Rad
A group of type 1 antibodies recently made available by Bio-Rad Laboratories are intended to prevent the drug evolcumab from attaching to its target,...
News
For $1.1 Billion, Novo Nordisk To Buy Forma Therapeutics
On September 1, 2022, Novo Nordisk and Forma Therapeutics revealed that Novo Nordisk would buy Forma Therapeutics for for $1.1 billion. With the purchase...
Drug Research
Merck Assesses 5 Years of Keytruda Lung Cancer Research
By demonstrating a massive survival benefit, Keytruda's Keynote-189 study precipitated a turning point in the development of lung cancer medications. Merck & Co. is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read